Vandraas K, Naume B, Sætersdal A, Blix E (2026)
HER2-positiv brystkreft
Tidsskr Nor Laegeforen, 146 (10)
DOI 10.4045/tidsskr.26.0199, PubMed 42708992

Gondaliya P, Zinn DA, Sayyed AA, Driscoll J, Yan IK, Mensali N, Wälchli S, Patel T (2026)
Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells
Mol Pharm, 23 (9), 4540-4552
DOI 10.1021/acs.molpharmaceut.6c00219, PubMed 42704135

Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD (2026)
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70326, PubMed 42703809